Di Stefano, V.; Mancarella, M.; Camporeale, A.; Regalia, A.; Ferraresi, M.; Pisaniello, M.; Cassinerio, E.; Pieruzzi, F.; Motta, I.
Migalastat Treatment in a Kidney-Transplanted Patient with Fabry Disease and N215S Mutation: The First Case Report. Pharmaceuticals 2021, 14, 1304.
https://doi.org/10.3390/ph14121304
AMA Style
Di Stefano V, Mancarella M, Camporeale A, Regalia A, Ferraresi M, Pisaniello M, Cassinerio E, Pieruzzi F, Motta I.
Migalastat Treatment in a Kidney-Transplanted Patient with Fabry Disease and N215S Mutation: The First Case Report. Pharmaceuticals. 2021; 14(12):1304.
https://doi.org/10.3390/ph14121304
Chicago/Turabian Style
Di Stefano, Valeria, Marta Mancarella, Antonia Camporeale, Anna Regalia, Marta Ferraresi, Marco Pisaniello, Elena Cassinerio, Federico Pieruzzi, and Irene Motta.
2021. "Migalastat Treatment in a Kidney-Transplanted Patient with Fabry Disease and N215S Mutation: The First Case Report" Pharmaceuticals 14, no. 12: 1304.
https://doi.org/10.3390/ph14121304
APA Style
Di Stefano, V., Mancarella, M., Camporeale, A., Regalia, A., Ferraresi, M., Pisaniello, M., Cassinerio, E., Pieruzzi, F., & Motta, I.
(2021). Migalastat Treatment in a Kidney-Transplanted Patient with Fabry Disease and N215S Mutation: The First Case Report. Pharmaceuticals, 14(12), 1304.
https://doi.org/10.3390/ph14121304
